- abnormal spleen morphology / MGI
- demyelination / MGI
- decreased IgG level / MGI
- decreased IgM level / MGI
- brain inflammation / MGI
- abnormal T cell differentiation / MGI
- no abnormal phenotype detected / MGI
- abnormal lymph node T cell domain morphology / MGI
- abnormal double-positive T cell morphology / MGI
- increased susceptibility to viral infection / MGI
- abnormal CD4-positive, alpha beta T cell morphology / MGI
- decreased immunoglobulin level / MGI
- abnormal immune system organ morphology / MGI
- no phenotypic analysis / MGI
- absent CD4-positive, alpha beta T cells / MGI
- abnormal T cell subpopulation ratio / MGI
- abnormal bile salt level / MGI
- decreased susceptibility to autoimmune diabetes / MGI
- abnormal CD8-positive, alpha beta T cell morphology / MGI
- decreased T cell number / MGI
- increased susceptibility to parasitic infection / MGI
- increased double-positive T cell number / MGI
- decreased double-positive T cell number / MGI
- decreased T cell proliferation / MGI
- immune system phenotype / MGI
- abnormal CD4-positive, alpha-beta T cell physiology / MGI
- increased CD4-positive, alpha beta T cell number / MGI
- decreased CD4-positive, alpha beta T cell number / MGI
- increased CD8-positive, alpha-beta T cell number / MGI
- absent plasma cells / MGI
- impaired humoral immune response / MGI
C57BL/6NTac-Cd4tm2(EGFP/cre/ERT2)Wtsi/Cnrm
Status | Available to order |
EMMA ID | EM:09153 |
International strain name | C57BL/6NTac-Cd4tm2(EGFP/cre/ERT2)Wtsi/Cnrm |
Alternative name | CEPD0081_2_A02 |
Strain type | |
Allele/Transgene symbol | Cd4tm2(EGFP/cre/ERT2)Wtsi |
Gene/Transgene symbol | Cd4 |
Information from provider
Provider | CNR, Consiglio Nazionale delle Ricerche |
Provider affiliation | EMMA-Monterotondo Campus International Development, CNR, Consiglio Nazionale delle Ricerche |
Genetic information | This mouse line originates from EUCOMM ES clone CEPD0081_2_A02. For further details on the construction of this clone see the page at the IMPC portal. Quality Control/Disclaimer: The structure of the targeted mutation is not fully verified. It is recommended that the recipient confirms the mutation structure by Southern blotting. The Cre expression pattern is expected to mirror that of the host gene, but this may not be fully described and/or may be modified in the targeted allele. Although characterisation of the Cre expression pattern is an objective of EUCOMMTools this is an ongoing process which may be incomplete. It is therefore recommended that the recipient verifies the Cre expression pattern. For the tm2(EGFP/Cre/ERT2) type allele, if the promoter-driven selection cassette is flanked with Rox sites, it may be removed using Dre recombinase. Please be aware that the strain description may be subject to change. For the most recent description please consult the information pages for the appropriate product details at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
MGI phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).